25. High-risk genetic variants underlie unfavorable prognosis of B-lymphoblastic leukemia patients of Hispanic ethnicity

by achatfield@ezav.biz | Aug 16, 2023 | 0 - Show All, 04. Hematologic Malignancies

Maximilian Wengyn   Abstract Maximilian Wengyn, Alexandra E. Kovach, Andrew Doan, My H. Vu, Gordana Raca, Deepa Bhojwani Children’s Hospital Los Angeles, Los Angeles, CA, United States Compared to other ethnicities, Hispanics have a high incidence of acute...

39. Genomic microarray analysis reveals heterogeneity in high hyperdiploid B-cell acute lymphoblastic leukemia

by achatfield@ezav.biz | Aug 16, 2023 | 0 - Show All, 04. Hematologic Malignancies

Julie Feusier Abstract Julie Feusiera, Rotem Fishel Ben-Kenanb, Denise Quigleya, Erica Andersenc, Bo Hongc aARUP Laboratories, Salt Lake City, UT, United States; bDepartment of Hematology Oncology, Phoenix Children’s, Phoenix, AZ, United States; cARUP...

67. Target capture NGS for use in molecular-based research of myeloid measurable residual disease

by achatfield@ezav.biz | Aug 9, 2023 | 0 - Show All, 04. Hematologic Malignancies

Rebecca Biloune Rebecca completed a PhD in Neurochemistry at UCL, and has worked as a product manager at various biotechnology companies, with focus on product portfolios including sample preparation, reagents, instrumentation, software and applications for deployment...

74. Genomic analyses of Hodgkin and non-Hodgkin composite lymphomas identifies shared somatic mutations indicative of common clonal origin

by achatfield@ezav.biz | Aug 9, 2023 | 0 - Show All, 04. Hematologic Malignancies

Felicia Gomez Dr. Gomez is an Assistant Professor in the Griffith and Fehniger Laboratories within the Department of Medicine and the Division of Oncology at Washington University School of Medicine. Dr. Gomez is leading a deep sequencing analysis of Hodgkin lymphoma...

86. Diagnostic challenges of high-grade myeloid malignancies with partial plasmacytoid dendritic cell differentiation

by achatfield@ezav.biz | Aug 9, 2023 | 0 - Show All, 04. Hematologic Malignancies

Karen Nahmod Dr. Karen Nahmod obtained her Medical degree (MD) and a Ph.D. in Immunology from the University of Buenos Aires, Argentina, where she graduated with Honors. Since very early, she has been actively involved in teaching, including Biochemistry,...

89. TCF3::ZNF384 in a Peruvian girl with mixed-phenotype acute leukemia and poor treatment outcome

by achatfield@ezav.biz | Aug 9, 2023 | 0 - Show All, 04. Hematologic Malignancies

Richard S. Rodriguez Medical Geneticist at Instituto Nacional de Salud del Nio San Borja of Peru and graduate of the Master’s program in Epidemiological Research at Cayetano Heredia University. Main research interests in analysis and clinical interpretation of...